,ug/ml lower in the agar dilution method than in the CSMHB microdilution method, despite monitoring of the agar for cation content through performance disk diffusion testing with P. aeruginosa ATCC 27853. Tobramycin activity was greater than gentamicin activity, and susceptibility to tobramycin ranged from 89 to 97%, with few statistically significant differences noted among the seven methods studied. Differences in MIC distribution and geometric mean MIC between agar dilution and CSMHB microdilution testing were minimal and suggested less of a cation influence on tobramycin than gentamicin results. Although amikacin was also more active than gentamicin (83 to 99% of isolates were susceptible), differences in the amikacin results among methods tended to reflect the same trends in reporting as seen with gentamicin testing, with the exception that results of Avantage testing were similar to those of disk diffusion, CSMHB microdilution, Sensititre, and Vitek. A difference in geometric mean MIC of 5 ,ug/ml between CSMHB testing and agar dilution testing suggested the influence of divalent cations on amikacin results. Few highly significant differences were noted among methods when isolates were tested against carbenicillin and piperacillin, except that Avantage piperacillin results (66% susceptible) and Autobac piperacillin results (98% susceptible) were noticeably different from the percent piperacillin susceptibility (range, 85 to 92%) measured by the other methods. Method-dependent variability among aminoglycoside susceptibility results, particularly when testing gentamicin, prevents meaningful comparison of Pseudomonas susceptibility trends among hospitals when different methods are used and promotes confusion and frustration among clinical microbiologists and clinicians owing to the uncertainties of the clinical meaning of these data.
Successful management of infections caused by Pseudomonas aeruginosa requires prompt, aggressive, and appropriate antimicrobial therapy. Detecting resistance of this organism in vitro, particularly to the widely used aminoglycoside group of antibiotics, may exert substantial influence on the selection of therapeutic agents by the physician. To generate these data, a variety of antimicrobial susceptibility testing (AST) methods, both conventional and instrument associated, are available to the clinical microbiologist. Despite differences in technical approach, all methods, ideally, should produce similar results and should demonstrate good performance when compared with a chosen reference method.
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However, disagreement among results generated by even conventional susceptibility testing methods (i.e., agar dilution, agar disk diffusion, and macrodilution or broth microdilution) when testing P. aeruginosa has been the subject of numerous reports (2, 5, 22, 23, 28, 30) . Efforts to resolve these disagreements have focused on controlling the factors influencing test results, including inoculum size (25, 26) and the divalent cation concentration of the growth medium (4, 12, 20, 22, 24, 27) . Consensus groups, such as the National Committee for Clinical Laboratory Standards (NCCLS), have made specific procedural recommendations for each of these reference AST methods to improve intra-and interlaboratory accuracy and precision (16, 17) . However, variation in results observed among different methods is likely to persist owing to the inherent difficulties in medium standard-ization and definition of an endpoint of a highly dynamic biological process. Furthermore, the introduction of rapid, nonconventional approaches to susceptibility testing has introduced additional variables, such as altered inoculum size, medium content, growth detection mechanism, and incubation interval, which may account for reported discrepancies between newer methods and reference procedures (M. S. Gradus, C. N. Baker, and C. Thornsberry, Antimicrob. Newsl. 2:73-82, 1985) .
In one of our laboratories, discrepant results were observed between two technically distinct methods used for determining the susceptibility of P. aeruginosa to aminoglycoside antibiotics, suggesting a method-dependent variation in results. To confirm this observation, we examined parallel results generated by a variety of routinely utilized susceptibility testing methods for P. aeruginosa tested against commonly used aminoglycosides and selected beta-lactam antimicrobial agents. The intent was not to revalidate the methods studied, since the controversies in the susceptibility-testing literature leave no foundation for the adoption of a definitive standard for Pseudomonas testing, or to compare the results of a single isolate when tested by multiple methods. Rather, we sought to compare, in a setting reflecting the testing environment of the clinical laboratory, the characterization of a given population of P. aeruginosa isolates among such methods with respect to susceptibility and resistance.
MATERIALS AND METHODS
Organisms. A total of 150 clinical isolates of P. aeruginosa, identified by standard criteria, were collected. Each of three area hospital microbiology laboratories (The Christ Hospital, Good Samaritan Hospital, and University Hospital, all in Cincinnati) contributed 50 isolates to the study pool. On the basis of susceptibility results from the method routinely used by that laboratory, isolates were selected within each participating laboratory to reflect a variety of categorical susceptibility patterns and the widest possible range of MICs. The sources of these isolates included blood, sputum, wounds, and body fluids, and care was taken not to include more than one isolate from a single patient, regardless of source, in the collection. Following overnight culture on tryptic soy agar supplemented with 5% defibrinated sheep blood (SBA), 5 to 10 isolated colonies of each strain were suspended in a solution of 2% peptone mixed with an equal part of glycerol. Three aliquots of the suspension were prepared and frozen at -70°C. A frozen aliquot of each isolate was distributed to each participating laboratory for testing by one or more designated AST methods.
Before being tested, organisms were thawed and cultured to SBA. These cultures were incubated at 35°C under 5 to 7% carbon dioxide for 18 to Calculations and statistical analyses. For comparison of differences among the groups of data generated by each method for each antimicrobial agent, the result for each isolate by a given method was paired with the result for the same isolate by the comparison method. The Statpac statistical analysis package (26) was used to determine the significance of observed differences between two methods by Student's t test. A probability of less than 0.05 was considered to represent a statistically significant difference between the two methods compared. Analysis was carried out between all possible pairings of methods for each drug studied. For analysis of qualitative data, each interpretative category was converted to a numerical value (susceptible = 1, intermediate = 2, resistant = 3). To determine the geometric mean MICs when comparing quantitative methods, we converted MIC results to log2 + 9, averaged them, and reconverted them to MICs (25) .
RESULTS
Qualitative results-aminoglycoside antimicrobial agents. Results generated by each test method are shown in Table 1 .
For ease of comparison, the MIC results by agar dilution and broth microdilution were converted to an interpretative category by using current NCCLS guidelines (16). These data reveal a technique-dependent difference among results from the seven methods tested, which was especially noticeable when they were tested for gentamicin.
(i) Gentamicin. On the basis of the percentage of isolates called susceptible by each method, two groupings of methods were apparent. Autobac, Avantage, and agar dilution were associated with susceptibility percentages ranging from 88 to 97%, whereas agar disk diffusion, broth microdilution, Vitek, and Sensititre AutoBP showed susceptibility percentages ranging from 60 to 67%. The distribution of isolates into either the intermediate or resistant category within each method examined was roughly equivalent. The number of isolates falling into either of these two categories, however, was larger in the second grouping of methods. Among methods considered conventional, there was no statistically significant difference between the data generated by agar disk diffusion and broth microdilution, whereas differences between either of these two methods and the third method, agar dilution, were highly significant (P < 0.001) ( (iii) Amikacin. As with gentamicin, technique-dependent differences were seen with the amikacin qualitative data (Table 1) , although the differences were much less marked than those observed with gentamicin. Disk diffusion, broth microdilution, Avantage, Sensititre AutoBP, and Vitek results were in good agreement with regard to P. aeruginosa susceptibility; the population was characterized as being largely susceptible (range, 83 to 90%). No method among this group was found to be statistically different from any other method within this group. However, agar dilution and Autobac results were similar to one another and were significantly different from those of the other methods tested, in that isolates were more likely to be characterized as susceptible, and only one isolate was considered to be resistant.
Qualitative results-beta-lactam antimicrobial agents. Qualitative results of testing the P. aeruginosa isolates against the two beta-lactam antibiotics used in this study (carbenicillin and piperacillin) are given in Table 1. (i) Carbenicillin. The Autobac and the Sensititre AutoBP methods tended to produce more susceptible results than the other methods did. Although these results were statistically different from those of other methods, the significance was not high (P < 0.05). The results were similar to those of broth microdilution, although the broth microdilution results were calculated to be significantly different only from the Vitek results (P < 0.05) when comparison was made beyond Autobac and Sensititre AutoBP. Fig. 1 . Agar dilution results showed a fourfold shift downward (toward susceptibility) in the modal MIC for these isolates (from 4 to 1 ,ug/ml) when compared with either broth microdilution and Vitek results. The gentamicin geometric mean MIC was accordingly much lower (2 ,ug/ml) for agar dilution testing than for either broth microdilution (6.04 ,ug/ml) or the Vitek system (5.16 ,ug/ml).
(ii) Tobramycin. The quantitative data, like the qualitative data, were in fairly close agreement for tobramycin among the three methods (Fig. 2) analyses. GIBCO agar used for disk diffusion had 19 mg of calcium per liter and 50 mg of magnesium per liter, whereas the Difco agar used for agar dilution had 13 mg of calcium per liter and 73 mg of magnesium per liter. However, despite this variation, the sizes of zones of inhibition produced by the control strain of P. aeruginosa when tested on these media against aminoglycoside disks were well within recommended limits. Throughout the study, all control runs of organisms appropriate for each testing method were found to be within published limits (16, 17).
DISCUSSION
Numerous factors besides AST results influence the choice of antimicrobial agents by a physician, including the site and severity of the infection, the clinical and immunological status of the patient, the pharmacology and toxicity of the drug, the clinical experience of the physician in treating certain disease syndromes, and the direct and indirect costs of therapy. However, the AST result remains a prominent and frequently used factor in the selection of a particular antimicrobial agent. Although the microbiologist views the AST as an expression of the in vitro relationship between an organism and a drug tested under a given or standardized set of conditions, there is a tendency among clinicians to assign a predictive therapeutic value to the laboratory results. If in vitro relationships as measured by AST are to be meaningful clinically, a consistent and reproducible laboratory data base is necessary. To that end, the microbiological community has endeavored over the last three decades to emphasize rigid standardization in the testing of bacteria against antimicrobial agents in the clinical laboratory. Despite this effort, the observations of this trial on parallel testing of seven commonly used AST methods, all meeting recommended control criteria, with respect to P. aeruginosa and aminoglycoside antimicrobial agents reveal a disconcerting pattern.
In this study, the clinical isolates of P. aeruginosa were characterized as largely susceptible to gentamicin by accepted criteria if tested by agar dilution, Autobac, or Avantage. In Table 2 ), suggesting that AST results for gentamicin and P. aeruginosa are very much method dependent.
The large number of susceptible characterizations by agar dilution compared with broth microdilution calls attention to the longstanding problem of divalent cation content and its influence on susceptibility testing of aminoglycoside antibiotics against P. aeruginosa. The progressive increase in aminoglycoside MIC against Pseudomonas spp. as the concentrations of calcium or magnesium, or both, are increased in the test medium has been well documented (6, 10, 11, 14, 31) . Broth dilution results for aminoglycosides against Pseudomonas spp. generally gave lower MICs than agar dilution testing, presumably because the agar contained more cations than the broth did. These observations led to the recommendation that cation-deficient broth be supplemented with near physiologic levels of calcium and magnesium to bring into better agreement aminoglycoside results of broth and agar methods (15, 22) . Although the use of CSMHB has become nearly universal, a recent study by Barry et al. (1) has demonstrated an improved concordance of results between agar dilution and broth dilution methods when testing an aminoglycoside, netilmicin, with a Mueller-Hinton broth having cation levels one-half those currently recommended. Perhaps as a result, the NCCLS has proposed just such a change in cation supplementation for CSMHB in document M7-T2 (19) . The impact on results for aminoglycosides against Pseudomonas spp. when this altered broth is used may be substantial for both hospital laboratory and industry practices. Shifts are likely to be noted in susceptibility patterns among hospitals testing with the systems based on current CSMHB. Also, formulations of media for commercial microdilution systems and rapid automated methods may require similar alteration and reevaluation to provide results consistent with those obtained by using the newly proposed standard broth.
Assessing the effect of cations in agar on the performance of agar-based methods has been problematic. Pollak and co-workers (12, 20) found that cations may be distributed among insoluble, soluble, and ionized pools in agar, with the biological effect residing probably in the ionized pool, and that the distribution of the added cations among the various pools cannot be easily controlled. Furthermore, Washington et al. (27) have pointed out that the relationship between cation content and MIC seen in broth testing does not necessarily hold when a correlation between the total content of various cations in agar and the performance in agar dilution testing of Pseudomonas spp. is attempted. These findings challenge the usefulness of agar cation level analysis as a means of predicting method performance. An alternative approach is to evaluate agar medium based on performance testing with P. aeruginosa ATCC 27853. Such a recommendation has been defined in NCCLS document M6-P (18), which encourages standardization of MHA against a national "reference lot," during the manufacturing process by using specified biological performance criteria. The current NCCLS AST recommendations, therefore, do not call for cation supplementation or measurement in agarbased media (16, 17).
In the present study, despite rigid adherence to recommended performance criteria for agar-based media and the presence of physiologic levels of calcium and magnesium in broth-based methods, the results of agar dilution methods differed significantly from those of agar disk diffusion and from that of broth microdilution testing in CSMHB, the last two methods yielding comparable results. Presumably, a cation effect is responsible, indicating that the problem is far from resolved when the current performance criteria approach to medium evaluation is used. Inspection of the frequency distribution of gentamicin MICs between agar dilution and broth microdilution (Fig. 1) clearly shows a shift toward resistance when CSMHB is used. In contrast, such a shift between the two methods was not apparent (data not shown) for carbenicillin of piperacillin MICs, since the testing of beta-lactam antimicrobial agents is largely unaffected by the cation content of media.
The differences in gentamicin results with Autobac or Avantage and those with agar disk diffusion are disquieting, since presumably these rapid turbidometric methods were designed to mimic the performance of standard disk diffusion. Our observations are not surprising, given the findings of Gradus et al. (Antimicrob. Newsl.), who, upon reviewing the literature of studies comparing newer AST methodologies with conventional susceptibility testing, found that the most frequently reported problems were among results of aminoglycoside testing against Pseudomonas spp. As with broth dilution, cation supplementation of the standard broth formulation used in the Avantage system caused results, particularly for gentamicin and amikacin testing ( (Table 3) . Only a few isolates were shifted toward resistance, and this occurred only when the gentamicin disk mass was lowered appreciably from the standard 9 to 3 ,ug. Thus, other mechanisms such as inoculum heterogeneity, described by Mayo et al. (13) as a source of false-susceptible gentamicin results for some isolates with Autobac, may be responsible for this phenomenon. Although no resistant subpopulation was detected among isolates when tested by agar dilution, the phenomenon was specifically not examined in our study. Whatever the mechanism, users of the Autobac method should be aware that estimates ofthe susceptibility of P. aeruginosa to gentamicin are likely to be considerably greater than estimates made by standard disk diffusion or broth microdilution methods using CSMHB.
In contrast, two other instrumentation methods, Sensititre AutoBP and Vitek, produced results comparable to those of the disk diffusion of CSMHB microdilution procedures. In the Sensititre technology, fluorogenic enzyme substrates incorporated into the CSMHB assay medium are hydrolyzed by microbial enzymes produced during growth, releasing a detectable fluorescent product. The test uses overnight incubation of the organism in CSMHB with substrate, and thus the conditions closely paralleled those of broth microdilution. In a previous report by Dorn et al. (9) , a high concordance was found between results of fluorogenic tests and those of manual reading of a parallel series of control breakpoint plates for P. aeruginosa testing. Therefore, a similarity of aminoglycoside results from Sensititre AutoBP and conventional microdilution testing in CSMHB was expected. The Vitek GNS card yields results after approximately 10 h of incubation, and these data were comparable to those of disk diffusion or conventional broth microdilution with CSMHB. Because the assay broth used in the Vitek method contains cation supplementation, this agreement is not surprising. Woolfrey et al. (29) have reported that when Vitek results for aminoglycoside activity against P. aeruginosa were compared with a small-increment broth microdilution reference, the Vitek results were distinctly higher, but owing to the nature of the present study, this observation could neither be supported nor denied.
The testing of P. aeruginosa isolates against tobramycin revealed far less method-to-method variation in results than those observed with gentamicin. Regardless of the method used, the 150 isolates of P. aeruginosa were generally categorized as being susceptible to tobramycin. Tobramycin activity against P. aeruginosa on a per-unit-weight basis has been shown to be greater than that of gentamicin (3, 21 (Fig. 2) than with gentamicin testing (Fig. 1) . It is tempting to speculate that the cation influence on tobramycin activity is smaller than on gentamicin activity. Earlier work suggesting that the influence of serum in decreasing both bactericidal and inhibitory activity of aminoglycosides as measured in cation-deficient broth is smaller on tobramycin than on gentamicin (7, 8) Data collected for the beta-lactams (carbenicillin and piperacillin) showed a much greater homogeneity of results among methods than did data for the aminoglycosides. Frequency distribution curves of MIC categories generated by agar dilution and broth microdilution could be superimposed, suggesting that cation content has little influence on the activity of these two agents.
The study has provoked several interesting and complex issues. Clearly, AST of P. aeruginosa against aminoglycosides, particularly gentamicin, is technique or method dependent. Present standards set criteria for variables such as inoculum size, medium composition, antimicrobial agent concentration, and incubation time. It is also suggested that the cation content of the medium be monitored by either biological performance for agar-based methods or absolute levels for broth dilution. However, during testing in an experienced clinical laboratory, following national consensus procedures and guidelines, one NCCLS reference method (agar dilution) did not produce gentamicin results comparable to those of two other methods listed as or based upon reference procedures (disk diffusion and broth microdilution). The inability to control the level of biologically active cations in agar should perhaps prompt consideration of testing Pseudomonas spp. and aminoglycosides only in broth, in which the impact of cation content on test results appears to be at least consistent.
Importantly, such variation in AST testing directly influences the susceptibility profiles of P. aeruginosa to aminoglycosides in a given hospital and makes difficult the comparison of these data among hospitals whose laboratories use different AST methodologies. In addition, any laboratory that switches from a rapid turbidometric method, which tends to underestimate resistance, to an overnight incubation method or to the Vitek instrument is likely to observe an abrupt shift in the apparent resistance of the P. aeruginosa population in that hospital, particularly with respect to gentamicin. In one of our laboratories (J.L.S.), a change from Autobac to a CSMHB microdilution method resulted in a change in the gentamicin statistics among P. aeruginosa from 89% susceptible one year to 55% susceptible the next. No doubt, adoption of a change in cation content tentatively proposed by the NCCLS M7-T2 document (19) would push the susceptibility percentages upward again. Given the dilemmas involved in predicting from a test tube the success or failure of antibiotic therapy, laboratory workers must caution physicians that the clinical implications of such methoddependent shifts are uncertain. However, such data, rightly or wrongly, will affect prescribing patterns and possibly pharmacy inventory policies. Few physicians would be comfortable treating patients with antibiotics to which the organism is characterized as resistant or even intermediate by the laboratory when other similar antibiotics, to which the organism is reported as susceptible, are available. Therefore, laboratories are prompted to proceed with the greatest of caution in the interpretation of P. aeruginosa AST data and to be cognizant of the influence of the method by which such data are generated.
